DGX Quest Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NYSE: DGX

Price (delayed)

$145.59

Market cap

$16.21B

P/E Ratio

19.41

Dividend/share

$2.92

EPS

$7.5

Enterprise value

$21.02B

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals ...

Highlights
Quest Diagnostics's quick ratio has increased by 8% YoY
DGX's EPS is up by 7% year-on-year
Quest Diagnostics's debt has decreased by 4.9% QoQ but it has increased by 2.6% YoY
DGX's price to earnings (P/E) is 31% higher than its 5-year quarterly average of 14.8 and 8% higher than its last 4 quarters average of 18.0
The gross profit has decreased by 3.9% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.questdiagnostics.com/
Peers: LH NEO ENZ QGEN

Key stats

What are the main financial stats of DGX
Market
Shares outstanding
111.32M
Market cap
$16.21B
Enterprise value
$21.02B
Valuations
Price to earnings (P/E)
19.41
Price to book (P/B)
2.44
Price to sales (P/S)
1.73
EV/EBIT
16.75
EV/EBITDA
12.31
EV/Sales
2.25
Earnings
Revenue
$9.35B
EBIT
$1.26B
EBITDA
$1.71B
Free cash flow
$875M
Per share
EPS
$7.5
Free cash flow per share
$7.88
Book value per share
$59.56
Revenue per share
$84.2
TBVPS
$43.19
Balance sheet
Total assets
$13.88B
Total liabilities
$7.23B
Debt
$5.09B
Equity
$6.62B
Working capital
$5M
Liquidity
Debt to equity
0.77
Current ratio
1
Quick ratio
0.79
Net debt/EBITDA
2.82
Margins
EBITDA margin
18.3%
Gross margin
32.8%
Net margin
9%
Operating margin
13.5%
Efficiency
Return on assets
6.1%
Return on equity
13%
Return on invested capital
16.3%
Return on capital employed
10.6%
Return on sales
13.4%
Dividend
Dividend yield
2.01%
DPS
$2.92
Payout ratio
38.9%

DGX stock price

How has the Quest Diagnostics stock price performed over time
Intraday
0.93%
1 week
-0.29%
1 month
5.04%
1 year
6.86%
YTD
5.59%
QTD
6.36%

Financial performance

How have Quest Diagnostics's revenue and profit performed over time
Revenue
$9.35B
Gross profit
$3.07B
Operating income
$1.26B
Net income
$840M
Gross margin
32.8%
Net margin
9%
The company's operating margin rose by 9% YoY
Quest Diagnostics's net margin has increased by 7% YoY
DGX's operating income is up by 7% year-on-year
The net income has grown by 6% YoY

Growth

What is Quest Diagnostics's growth rate over time

Valuation

What is Quest Diagnostics stock price valuation
DGX P/E details
P/E
19.41
P/B
2.44
P/S
1.73
EV/EBIT
16.75
EV/EBITDA
12.31
EV/Sales
2.25
DGX's price to earnings (P/E) is 31% higher than its 5-year quarterly average of 14.8 and 8% higher than its last 4 quarters average of 18.0
DGX's EPS is up by 7% year-on-year
Quest Diagnostics's equity has increased by 6% YoY and by 2.9% from the previous quarter
The stock's price to book (P/B) is 6% more than its last 4 quarters average of 2.3 but 2.4% less than its 5-year quarterly average of 2.5
The stock's price to sales (P/S) is 8% more than its last 4 quarters average of 1.6

Efficiency

How efficient is Quest Diagnostics business performance
DGX's return on sales is up by 11% year-on-year
Quest Diagnostics's return on invested capital has increased by 4.5% YoY
DGX's ROE is down by 2.3% since the previous quarter

Dividends

What is DGX's dividend history
Dividend details
DPS
$2.92
Dividend yield
2.01%
Payout ratio
38.9%
Recent dividends

Financial health

How did Quest Diagnostics financials performed over time
The total assets is 92% greater than the total liabilities
The current ratio has increased by 9% YoY and by 3.1% QoQ
Quest Diagnostics's quick ratio has increased by 8% YoY
Quest Diagnostics's debt is 23% lower than its equity
The company's debt to equity fell by 7% QoQ and by 2.5% YoY
Quest Diagnostics's equity has increased by 6% YoY and by 2.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.